Immunocore Holdings (IMCR) Short-term Investments (2019 - 2026)

Immunocore Holdings (IMCR) has reported Short-term Investments for 4 consecutive years, with $392.2 million the latest figure, recorded in Q1 2026.

• Quarterly Short-term Investments rose 8.89% year-over-year to $392.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $392.2 million (up 8.89% YoY) and the FY2025 annual result came in at $396.4 million, up 8.72% from the prior year.
• Short-term Investments fell to $392.2 million in Q1 2026 per IMCR's latest filing, from $396.4 million in the prior quarter.
• Over the last five years, Short-term Investments for IMCR reached as high as $396.4 million in Q4 2025 and fell as low as $354.6 million in Q2 2024.
• A 3-year average of $377.6 million and a median of $378.4 million in 2024 frame the typical range for Short-term Investments.
• The largest YoY upside for Short-term Investments was 11.36% in 2025 against a maximum downside of 8.37% in 2025.
• Year by year, Short-term Investments stood at $364.6 million in 2024, then advanced by 8.72% to $396.4 million in 2025, then dropped by 1.07% to $392.2 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $392.2 million, $396.4 million, and $393.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.